Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

Journal of Molecular Medicine

Volumn 73, Issue 7, 1995, Pages 333-346

  Battegay, E J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Angiogenesis; Angiogenesis factor; Angiogenesis inhibtion; Cardiovascular diseases; Cellular phenotype; Diabetes mellitus; Endothelium; Growth factors; Neovascularization; Treatment; Tumor

Indexed keywords

FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; CANCER; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ENDOTHELIUM; HUMAN; REVIEW; WOUND HEALING;

ANIMAL; HUMAN; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SUPPORT, NON-U.S. GOV'T;

EID: 0029121235     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/BF00192885     Document Type: Review

References (178)

1. Elevated vascular permeability factor/vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
2. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases
3. Erythropoietin receptor mRNA expression in human endothelial cells
4. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes
5. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during angiogenesis
6. Fibroblast growth factors
7. The effects of platelet-derived growth factor in cultured microvessel endothelial cells
8. Hypothesis: vasa vasorum and neovascularization of human coronary arteries
9. Regressing thin cutaneous malignant melanomas (< or =1.0 mm) are associated with angiogenesis
10. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
11. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF β-receptors
12. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium
13. Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells
14. Human microvascular endothelial cells express receptors for platelet-derived growth factor
15. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
16. Vascular targeting and the inhibition of angiogenesis
17. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis
18. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
19. Growth factors in endothelial regeneration
20. The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor
21. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only
22. Requirement of vascular integrin αvβ3 for angiogenesis
23. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
24. PDGF and TGF-β act synergistically to improve wound healing in the genetically diabetic mouse
25. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
26. Physiological consequences of loss of plasminogen activator gene function in mice
27. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct
28. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis
29. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
30. Clinical prognostic significance of tumour angiogenesis
31. Thalidomide is an inhibitor of angiogenesis
32. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
33. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects
34. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1
35. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis
36. Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression
37. Thrombin mitogenic responses and protein phosphorylation are different in cultured human endothelial cells derived from large and microvessels
38. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma
39. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS
40. Interferon-2a therapy for life-threatening hemangiomas of infancy
41. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue
42. Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor
43. Kidney regulation of erythropoietin production
44. Toward an understanding of angiogenesis: search and discovery
45. Angiogenesis in cancer, vascular, rheumatoid and other disease
46. Angiogenesis
47. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB
48. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
49. Vascular endothelial growth factor-its role in retinal vascular proliferation
50. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
51. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
52. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
53. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
54. Scatter factor induces blood vessel formation in vivo
55. Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization
56. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor
57. Inhibition of endothelial cell proiferation by platelet factor-4 involves a unique action on S phase progression
58. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts
59. Angiogenic activity of enzymes (letter)
60. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets
61. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
62. Angiogenesis during human extraembryonic development in 2 volves the spatiotemporal control of PDGF ligand and receptor gene expression
63. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
64. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
65. Basic fibroblast growth factor in gastric ulceration: mucosal levels and therapeutic potential
66. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis
67. Modulation of extracellular matrix by endothelial cells undergoing angiogenesis in vitro
68. Differential expression of extracellular proteins is correlated with angiogenesis in vitro
69. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-β1
70. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
71. Expression of decorin by sprouting bovine endothelial cells exhibiting angiogenesis in vitro
72. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
73. De novo generation of permanent neovascularized soft tissue appendages by platelet-derived growth factor
74. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
75. Angiogenesis
76. Interleukin-8 as a macrophage-derived mediator of angiogenesis
77. Vascular endothelial growth factor. a cytokine modulating endothelial function in rheumatoid arthritis
78. Endarteriitis und Arteriitis
79. Potential relevance of angiogenic factors to ovarian physiology
80. Oxygen tension regulates the expression of platelet-derived growth factor-B chain gene in human endothelial cells
81. Fibrogenic cytokines and connective tissue production
82. Endothelial cell implantation and survival within experimental gliomas
83. SPARC is a source of copper-binding peptides that stimulate angiogenesis
84. Dose responsive effects of PDGF-BB, PDGF-AA, EGF, and bFGF on granulation tissue in a guinea pig partial thickness skin excision model
85. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism
86. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation
87. Hypoxia induces glucose transporter expression in endothelial cells
88. Endothelial control of vascular tome in large and small coronary arteries
89. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin
90. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
91. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
92. Inhibition of membrane biosynthesis prevents angiogenesis
93. The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion
94. Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis
95. Transforming growth factor-β activity is potentiated by heparin via dissection of the transforming growth factor-β/α2-macroglobulin inactive complex
96. Growth factors are released by mechanically wounded endothelial cells
97. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects
98. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis
99. Glioblastoma growth inhibited in vivo by a dominantnegative Flk-1 mutant
100. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
101. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
102. Expression of platelet-derived endothelial growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity
103. 1992 Mack Forster Award Lecture. Review. Regulation of angiogenesis in vitro
104. Tumor necrosis factor α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis
105. A cartilage-derived inhibitor of neovascularization and metalloproteinases
106. Inhibitory action of transforming growth factor β on endothelial cells
107. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis
108. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo
109. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
110. Isolation and characterization of vasoformative endothelial cells from the rat aorta
111. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis
112. The cardiovascular and lymphatic systems
113. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
114. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo
115. Supression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and microtubule stabilizer taxol
116. Antigenic heterogeneity of vascular endothelium
117. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
118. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
119. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
120. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis
121. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells
122. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair
123. Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas
124. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
125. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
126. Enhanced revascularization of the ischemic limb by angiogenic therapy
127. Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study
128. The extracellular glycoprotein SPARC interacts with plateletderived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors
129. Regulation of the activity of a novel inhibitor of angiogenesis by a cancer suppressor gene
130. Vascular endothelial factor messenger ribonucleic acid expression in the primate ovary
131. Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans
132. Angiogenesis in the female reproductive system
133. Angiogenic growth factors
134. Embryonic angiogenesis factors
135. Angiogenesis and endothelial cell function
136. Platelet-derived growth factor is angiogenic in vivo
137. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers
138. The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis
139. Phenotypic diversity in cultured cerebral microvascular endothelial cells
140. Coronary collateral recruitment: functional significance and relation to rate of vessel closure
141. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-β1
142. Recent insights into coronary collateral circulation
143. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture
144. The collateral circulation of the heart
145. Molecular biologic concepts of coronary anastomoses
146. Growth factors and angiogenesis
147. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β
148. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system
149. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
150. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
151. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
152. Rat brain capillary endothelial cells express functional PDGF B-type receptors
153. Stable expression of human platelet-derived growth factor B chain by bovine aortic endothelial cells. Matrix association and selective proteolytic cleavage by thrombin
154. The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma
155. Interleukin-8. A corneal factor that induces neovascularization
156. Angiogenic processes in the pathogenesis of human coronary atherosclerosis
157. Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin
158. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein
159. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
160. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion foration in experimental cardiac allografts
161. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents
162. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
163. Functional significance of collaterals during ameroid-induced coronary stenosis in conscious dogs
164. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
165. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
166. Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro
167. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components
168. Tumor angiogenesis in prostatic carcinoma with and without bone metastasis; a morphometric study
169. Tumor angiogenesis: review of current applications in tumor prognostication
170. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
171. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor
172. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances
173. Treatment of childhood angiomatous diseases with recombinant interferon-2a
174. Safety and efficacy of an angiogenic peptide, basic fibroblast growth factor (bFGF) in the treatment of gastroduodenal ulcers: a preliminary report
175. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
176. Immunohistochemical study of intimal microvessels in coronary atherosclerosis
177. Angiogenesis can be stimulated or repressed in vivo by a change in GM3∶GD3 ganglioside ratio